Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.35 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.35 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.33 |
| ▸ | GPR3 | P46089 | 1/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20071440 | 0.85 | KDM4E (0.38) | KDM4EMEN1ALDH1A1POLBMAPT | |
| SCHEMBL31722640 | 0.81 | KDM4E (0.41) | KDM4EMEN1ALDH1A1POLBMAPT | |
| SCHEMBL20857812 | 0.80 | KDM4E (0.44) | KDM4EMEN1ALDH1A1POLBMAPT | |
| SCHEMBL20444568 | 0.79 | HKDC1 (0.35) | KDM4EMEN1ALDH1A1POLBMAPT | |
| SCHEMBL23487266 | 0.79 | NPC1 (0.31) | — | |
| SCHEMBL20857975 | 0.79 | KDM4E (0.42) | KDM4EMEN1ALDH1A1POLBMAPT | |
| SCHEMBL867663 | 0.78 | KDM4E (0.53) | KDM4EMEN1ALDH1A1POLBMAPT | |
| SCHEMBL29600269 | 0.78 | KDM4E (0.53) | KDM4EMEN1ALDH1A1POLBMAPT | |
| SCHEMBL25636917 | 0.78 | KDM4E (0.53) | KDM4EMEN1ALDH1A1POLBMAPT | |
| SCHEMBL25635131 | 0.78 | KDM4E (0.53) | KDM4EMEN1ALDH1A1POLBMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11787789-B2 | Compound for an organic electric element, an organic electric element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2023-10-17 | — | — | US | disclosed |
| US-11787789-B2 | Compound for an organic electric element, an organic electric element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2023-10-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11787789-B2 | Compound for an organic electric element, an organic electric element using the same, and an electronic device thereof | PIEZO1, ORAI2, OCIAD1 | KDM4E 1227/4885MEN1 366/4885ALDH1A1 957/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.